Management of dyskinesia in COMT-naive patients starting adjunctive therapy with opicapone: the BIPARK-I double-blind experience

被引：0
|
作者：
Pagonabarraga, J. [1 ]
Tolosa, E. [2 ]
Ferreira, J. [3 ]
Lees, A. [4 ]
Arbe, E. [5 ]
Rocha, J. [5 ]
Soares-Da-Silva, P. [6 ]
机构：
[1] Hosp Santa Creu & Sant Pau, Unit Movement Disorders, Neurol, Barcelona, Spain
[2] Hosp Clin Univ Barcelona, Parkinson Dis & Movement Disorder Unit, Barcelona, Spain
[3] Inst Med Mol, Neurol Clin Res Unit, Lisbon, Portugal
[4] Natl Hosp Neurol & Neurosurg, London, England
[5] BIAL Portela & Co SA, Global Parkinson Dis, Sao Mamede do Coronado, Portugal
[6] BIAL Portela & Co SA, Res & Dev, Sao Mamede do Coronado, Portugal
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR3069
引用
收藏
页码：516 / 516
页数：1
相关论文
共 50 条
  • [31] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 652 - 652
  • [32] Efficacy of opicapone in Parkinson's disease patients according to baseline presence of dyskinesia: a post-hoc analysis from combined BIPARK-I and II
    Lees, A.
    Ferreira, J.
    Antonini, A.
    Reichmann, H.
    Costa, R.
    Magalhaes, D.
    Rocha, J.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2019, 34 : S56 - S57
  • [33] Switching double-blind opicapone, entacapone or placebo to open-label opicapone: Efficacy results of the 1-year extension of study BIPARK I
    Ferreira, J.
    Lees, A.
    Tolosa, E.
    Poewe, W.
    Santos, A.
    Lopes, N.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2016, 31 : S633 - S633
  • [34] Change in OFF-/ON-Time After Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone in Patients who Ended the 1-Year BIPARK-I Extension Study on Opicapone 50mg
    Poewe, W.
    Ferreira, J. J.
    Lees, A.
    Rascol, O.
    Ikedo, F.
    Magalhaes, D.
    Rocha, J. -F.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 1101 - 1102
  • [35] OPICAPONE AS FIRST-LINE ADJUNCTIVE LEVODOPA TREATMENT IN PARKINSON'S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS: BIPARK-I AND II COMBINED POST-HOC ANALYSIS
    Ferreira, J. J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. F.
    Magalhaes, D.
    Soares-da-Silva, P.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E63 - E63
  • [36] Impact of switching from double-blind placebo or entacapone to open-label opicapone in non-motor symptoms scale: results from the 1-year extension BIPARK-I study
    Fabregues, O.
    Tolosa, E.
    Ferreira, J.
    Lees, A.
    Santos, A.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 465 - 465
  • [37] Efficacy of opicapone in Parkinson's disease patients with motor fluctuations: A phase III, randomized, double-blind, placebo and active-controlled study - BIPARK I
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-Silva, P.
    MOVEMENT DISORDERS, 2015, 30 : S85 - S86
  • [38] Impact of switching from double-blind placebo or entacapone to open-label opicapone in UPDRS-II and III scores in the open-label 1-year extension BIPARK-I study
    Ehret, R. -M.
    Ferreira, J.
    Stocchi, F.
    Ikedo, F.
    Arbe, E.
    Rocha, J.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 462 - 462
  • [39] Evaluation of efficacy of opicapone in Parkinson's disease patients with motor fluctuations: phase III, randomized, double-blind, placebo and active-controlled study (BIPARK I)
    Ferreira, J.
    Lees, A.
    Santos, A.
    Pinto, R.
    Lopes, N.
    Nunes, T.
    Rocha, J. F.
    Soares-da-silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 144 - 144
  • [40] Opicapone as First-Line Adjunctive Levodopa Treatment in Parkinson's Disease Patients with Motor Fluctuations: Findings from BIPARK-I and II Combined Post-Hoc Analysis
    Ferreira, J. J.
    Poewe, W.
    Antonini, A.
    Gama, H.
    Rocha, J. -F.
    Magalhaes, D.
    Soares-Da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 189 - 190
12345